Monoclonal Antibodies Core Unit

Home | Research & Innovation | Scientific Programmes | Biotechnology Programme | Monoclonal Antibodies Core Unit


  • Lorena Maestre
  • Ana Isabel Reyes
  • Andrea Belén Romero

The application of hybridoma technology for the production of monoclonal antibodies ( mAbs ) represents one of the most relevant methodological advances in biomedicine of the past decades. The availability of monoclonal antibodies has significantly improved our knowledge about the processes involved in tumour generation and development, opening up a vast array of new possibilities for basic and applied research.

The Monoclonal Antibodies Unit provides CNIO Research Groups with an ‘a la carte’ generation of mAbs. We are highly specialised in the production of mouse and rat monoclonal antibodies. The Unit also offers mAb characterisation and validation, medium-scale mAb production, as well as a service of Mycoplasma testing for the cell culture facility.